Immatics (IMTX) EBIT (2019 - 2025)
Immatics (IMTX) reported EBIT of -$41.7 million for Q4 2025, down 186.99% on a YoY basis from $47.9 million in Q4 2024, and up 30.08% sequentially from -$59.6 million in Q3 2025.
Immatics (IMTX) EBIT (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of EBIT data on file, last reported at -$41.7 million in Q4 2025.
- For the quarter ending Q4 2025, EBIT fell 186.99% year-over-year to -$41.7 million; the trailing twelve-month figure through Dec 2025 stood at -$264.8 million (down 2942.15% YoY), and the FY2025 full-year result was -$205.6 million, down 392.04% from the prior year.
- EBIT rose to -$41.7 million in Q4 2025, from -$59.6 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $94.9 million in Q1 2022 to a low of -$106.5 million in Q2 2025.
- A 5-year average of -$21.7 million and a median of -$26.5 million in 2023 frame the typical range for EBIT.
- Across the five-year window, EBIT soared 427.26% in 2022 and sank 2086.97% in 2025, its largest moves.
- Tracing IMTX's EBIT over 5 years: stood at -$19.6 million in 2021, then jumped by 53.86% to -$9.0 million in 2022, then tumbled by 245.92% to -$31.2 million in 2023, then soared by 253.24% to $47.9 million in 2024, then plunged by 186.99% to -$41.7 million in 2025.
- Business Quant data shows IMTX's EBIT at -$41.7 million in Q4 2025, -$59.6 million in Q3 2025, and -$106.5 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - | -41.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41.66 Mn |
| Sep 30, 2025 | -59.58 Mn |
| Jun 30, 2025 | -106.55 Mn |
| Mar 31, 2025 | -57.00 Mn |
| Dec 31, 2024 | 47.88 Mn |
| Sep 30, 2024 | -16.41 Mn |
| Jun 30, 2024 | -19.55 Mn |
| Mar 31, 2024 | -2.61 Mn |
| Dec 31, 2023 | -31.25 Mn |
| Sep 30, 2023 | -30.55 Mn |
| Jun 30, 2023 | -28.04 Mn |
| Mar 31, 2023 | -24.96 Mn |
| Dec 31, 2022 | -9.03 Mn |
| Sep 30, 2022 | -20.98 Mn |
| Jun 30, 2022 | -14.13 Mn |
| Mar 31, 2022 | 94.89 Mn |
| Dec 31, 2021 | -19.58 Mn |
| Sep 30, 2021 | -32.28 Mn |
| Jun 30, 2021 | -32.71 Mn |
| Mar 31, 2021 | -28.99 Mn |